Aurora Cannabis Inc. (ACB)
After hours:
| Previous close | 0.4907 |
| Open | 0.4860 |
| Bid | 0.5005 x 1300 |
| Ask | 0.5152 x 800 |
| Day's range | 0.4840 - 0.5220 |
| 52-week range | 0.4100 - 1.2050 |
| Volume | |
| Avg. volume | 21,474,767 |
| Market cap | 247.999M |
| Beta (5Y monthly) | 2.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
2 Popular Stocks to Avoid Like the Plague in 2024 and Beyond
Take, for instance, Aurora Cannabis (NASDAQ: ACB), a leader in the Canadian pot market, and Biogen (NASDAQ: BIIB), a notable biotech. Aurora Cannabis has consistently been one of the most talked-about stocks in the Canadian pot market since recreational adult use became legal some five years ago. Aurora Cannabis looks to be turning the corner, at least on the surface.
- Motley Fool
Is Aurora Cannabis Stock a Buy Now?
If you're a fan of investing in turnaround plays, Aurora Cannabis (NASDAQ: ACB) is a stock that you should probably know about. Aurora shareholders have had a (very) rough few years. Multiple factors are to blame, starting with its now-abandoned leave-no-customer-behind strategy, wherein it seriously overbuilt its cannabis production capacity as well as its retail footprint in an attempt to seize as much of the Canadian marijuana market as possible.
- Motley Fool
Down 99.5%, Is Now the Time to Buy Aurora Cannabis?
There just might be light at the end of the long, dark tunnel for this beleaguered cannabis company.
